Credit Suisse Ag Invitae Corp Call Options Transaction History

Credit Suisse Ag

  • $101 Billion
  • Q1 2024

Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2021

Nov 12, 2021
SELL
$24.31 - $33.6 $8.55 Million - $11.8 Million
-351,700 Reduced 95.47%
16,700 $475,000
Q2 2021

Aug 16, 2021
SELL
$26.09 - $40.4 $15,654 - $24,240
-600 Reduced 0.16%
368,400 $12.6 Million
Q1 2021

May 14, 2021
BUY
$33.06 - $56.93 $12.2 Million - $21 Million
369,000 New
369,000 $14.1 Million

Others Institutions Holding NVTA

# of Institutions
21
Shares Held
1.92M
Call Options Held
0
Put Options Held
0
View Full List

About Invitae Corp

NVTA Quotes by TradingView
  • Ticker NVTA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 235,266,000
  • Description
  • Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...
More about NVTA
Track This Portfolio

Track Credit Suisse Ag Portfolio

Follow Credit Suisse Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email